Xarelto Evidence in Real Life of Patients Preference and Satisfaction Study

Trial Profile

Xarelto Evidence in Real Life of Patients Preference and Satisfaction Study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 May 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms X-PRESS
  • Sponsors Bayer
  • Most Recent Events

    • 16 Mar 2017 Planned End Date changed from 1 Mar 2018 to 31 Mar 2018.
    • 16 Mar 2017 Planned primary completion date changed from 1 Dec 2017 to 31 Dec 2017.
    • 22 Feb 2017 Planned End Date changed from 1 Sep 2017 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top